Polymorphisms in the Non-Muscle Myosin Heavy Chain Gene (MYH9) Are Associated with Lower Glomerular Filtration Rate in Mixed Ancestry Diabetic Subjects from South Africa

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Matsha, Tandi Edith ^a   Masconi, Katya ^b   Yako, Yandiswa Yolanda ^b   Hassan, Mogamat Shafick ^a,b   Macharia, Muiriri ^b   Erasmus, Rajiv Timothy ^b   Kengne, Andre Pascal ^c  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; MYOSIN HEAVY CHAIN;

ADULT; AFRICAN AMERICAN; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA;

ADULT; ALBUMINURIA; CONFIDENCE INTERVALS; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENEALOGY AND HERALDRY; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY, CHRONIC; SOUTH AFRICA;

EID: 84871407912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052529     Document Type: Article

References (39)

1. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nature genetics 40: 1175-1184.
2. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nature genetics 40: 1185-1192.
3. Arrondel C, Vodovar N, Knebelmann B, Grunfeld JP, Gubler MC, et al. (2002) Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. Journal of the American Society of Nephrology: JASN 13: 65-74.
4. Kopp JB, (2010) Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism? Kidney international 78: 130-133.
5. Kitiyakara C, Eggers P, Kopp JB, (2004) Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. American journal of kidney diseases: the official journal of the National Kidney Foundation 44: 815-825.
6. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, et al. (1989) Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. The New England journal of medicine 321: 1074-1079.
7. Toto RD (2004) Proteinuria and hypertensive nephrosclerosis in African Americans. Kidney international Supplement: S102-104.
8. Fernandez M, Alarcon GS, Calvo-Alen J, Andrade R, McGwin G Jr, et al. (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis and rheumatism 57: 576-584.
9. Kopp JB, Winkler C (2003) HIV-associated nephropathy in African Americans. Kidney international Supplement: S43-49.
10. Behar DM, Rosset S, Tzur S, Selig S, Yudkovsky G, et al. (2010) African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Human molecular genetics 19: 1816-1827.
11. Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, et al. (2009) Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. American journal of nephrology 29: 626-632.
12. Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, et al. (2009) Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 24: 3366-3371.
13. Cooke JN, Bostrom MA, Hicks PJ, Ng MC, Hellwege JN, et al. (2012) Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 27: 1505-1511.
14. Zemlin AE, Matsha TE, Hassan MS, Erasmus RT, (2011) HbA1c of 6.5% to diagnose diabetes mellitus - does it work for us? - the Bellville South Africa study. PloS one 6: e22558.
15. Matsha TE, Hassan MS, Kidd M, Erasmus RT, (2012) The 30-year cardiovascular risk profile of South Africans with diagnosed diabetes, undiagnosed diabetes, pre-diabetes or normoglycaemia: the Bellville, South Africa pilot study. Cardiovascular journal of Africa 23: 5-11.
16. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, et al. (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clinical and experimental hypertension 21: 1009-1060.
17. WHO Consultation (1999) definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation.
18. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254.
19. Levey AS, Green T, Kusek JW, Beck GJ, (2000) A simplified equation to predict glomerular filtration rate from serum creatinin. J Am Soc Nephrol 11: 155A.
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
21. de Wit E, Delport W, Rugamika CE, Meintjes A, Moller M, et al. (2010) Genome-wide analysis of the structure of the South African Coloured Population in the Western Cape. Human genetics 128: 145-153.
22. Bostrom MA, Freedman BI, (2010) The spectrum of MYH9-associated nephropathy. Clinical journal of the American Society of Nephrology: CJASN 5: 1107-1113.
23. Cordonnier D, (1996) Glomerular involvement in type II diabetes- is it all diabetic glomerulosclerosis? Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 11: 936-938.
24. O'Seaghdha CM, Parekh RS, Hwang SJ, Li M, Kottgen A, et al. (2011) The MYH9/APOL1 region and chronic kidney disease in European-Americans. Human molecular genetics 20: 2450-2456.
25. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, et al. (2010) Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Human genetics 128: 345-350.
26. Sellers JR, (2000) Myosins: a diverse superfamily. Biochimica et biophysica acta 1496: 3-22.
27. Herrema H, Czajkowska D, Theard D, van der Wouden JM, Kalicharan D, et al. (2006) Rho kinase, myosin-II, and p42/44 MAPK control extracellular matrix-mediated apical bile canalicular lumen morphogenesis in HepG2 cells. Molecular biology of the cell 17: 3291-3303.
28. Perry J, Tam S, Zheng K, Sado Y, Dobson H, et al. (2006) Type IV collagen induces podocytic features in bone marrow stromal stem cells in vitro. Journal of the American Society of Nephrology: JASN 17: 66-76.
29. Saleem MA, Zavadil J, Bailly M, McGee K, Witherden IR, et al. (2008) The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. American journal of physiology Renal physiology 295: F959-970.
30. Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, et al. (2011) Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS genetics 7: e1002150.
31. Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, et al. (2011) Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. American journal of nephrology 33: 381-389.
32. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST, (2010) Diabetes in sub-Saharan Africa. Lancet 375: 2254-2266.
33. Levitt NS, Bradshaw D, (2006) The impact of HIV/AIDS on Type 2 diabetes prevalence and diabetes healthcare needs in South Africa: projections for 2010. Diabetic medicine: a journal of the British Diabetic Association 23: 103-104.
34. Levitt NS, (2008) Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94: 1376-1382.
35. Hall V, Thomsen RW, Henriksen O, Lohse N, (2011) Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC public health 11: 564.
36. Young F, Critchley JA, Johnstone LK, Unwin NC, (2009) A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Globalization and health 5: 9.
37. Medapalli RK, Parikh CR, Gordon K, Brown ST, Butt AA, et al. (2012) Comorbid Diabetes and the Risk of Progressive Chronic Kidney Disease in HIV-Infected Adults: Data From the Veterans Aging Cohort Study. Journal of acquired immune deficiency syndromes 60: 393-399.
38. Winkler C, (2010) Is there a genetic basis for health disparities in human immunodeficiency virus disease? The Mount Sinai journal of medicine, New York 77: 149-159.
39. Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA, (2010) Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PloS one 5: e11474.